Literature DB >> 34104328

Using Patient-Reported Outcomes toAssess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular Disease.

Raul Angel Garcia1, John A Spertus1.   

Abstract

Patient-reported outcomes (PROs) are elicited directly from patients so they can describe their overall health status, including their symptoms, function, and quality of life. While commonly used as end points in clinical trials, PROs can play an important role in routine clinical care, population health management, and as a means for quantifying the quality of patient care. In this review, we propose that PROs be used to improve patient-centered care in the treatment of cardiovascular diseases given their importance to patients and society and their ability to improve doctor- provider communication. Furthermore, given the current variability in patients' health status across different clinics and the fact that PROs can be improved by titrating therapy, we contend that PROs have a key opportunity to serve as measures of healthcare quality.

Entities:  

Keywords:  health status; patient-reported outcomes; patient­centered care; performance measures; psychometric properties; quality measures

Mesh:

Year:  2021        PMID: 34104328      PMCID: PMC8158443          DOI: 10.14797/VUWD7697

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  55 in total

1.  A strategy for health care reform--toward a value-based system.

Authors:  Michael E Porter
Journal:  N Engl J Med       Date:  2009-06-03       Impact factor: 91.245

2.  Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.

Authors:  Yevgeniy Khariton; Adrian F Hernandez; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Laine Thomas; Xiaojuan Mi; Nancy M Albert; Javed Butler; Kevin McCague; Michael E Nassif; Fredonia B Williams; Adam DeVore; J Herbert Patterson; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-04

3.  Validation of the Short Form 36 (SF-36) health survey questionnaire among stroke patients.

Authors:  C Anderson; S Laubscher; R Burns
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

4.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

5.  Development of a stroke-specific quality of life scale.

Authors:  L S Williams; M Weinberger; L E Harris; D O Clark; J Biller
Journal:  Stroke       Date:  1999-07       Impact factor: 7.914

6.  Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia.

Authors:  M B Morgan; T Crayford; B Murrin; S C Fraser
Journal:  J Vasc Surg       Date:  2001-04       Impact factor: 4.268

7.  Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study.

Authors:  Ali Shafiq; Suzanne V Arnold; Kensey Gosch; Faraz Kureshi; Tracie Breeding; Philip G Jones; John Beltrame; John A Spertus
Journal:  Am Heart J       Date:  2016-02-27       Impact factor: 4.749

8.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

Authors:  C P Green; C B Porter; D R Bresnahan; J A Spertus
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.

Authors:  M Fransen; J Edmonds
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

10.  The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study.

Authors:  John F Beltrame; Andrew J Weekes; Claire Morgan; Rosanna Tavella; John A Spertus
Journal:  Arch Intern Med       Date:  2009-09-14
View more
  1 in total

Review 1.  Epoxylipids and soluble epoxide hydrolase in heart diseases.

Authors:  John D Imig; Ludek Cervenka; Jan Neckar
Journal:  Biochem Pharmacol       Date:  2021-12-02       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.